Turki, A, Dall'Olio, D, Carota, L, Polizzi, S, Morote, M, Della Porta, M, Zhao, YM, Lanino, L, Sobas, M, Zhao, YQ, Sanchez, AH, Eric, S, Gimenez, LT, Abáigar, M, Elicegui, JM, Ramiro, AV, Dohner, K, Tettero, J, Esteve, J, Martinez-Lopez, J, Metzeler, K, Haferlach, T, Lehmann, S, Pratcorona, M, Thiede, C, Versluis, J, Mecklenbrauck, R, Heuser, M, Benner, A, Huntley, B, Rivas, JMH, Ossenkoppele, G, Döhner, H, Castellani, G, Bullinger, L. Independent, international validation of the unsupervised harmony classification of Acute Myeloid Leukemia. BLOOD. 2025; 146DOI:10.1182/blood-2025-451. PMID:. IF:23.100(Q1/1D).

Torres-Esquius, S, Gabarros-Subira, M, Gurnari, C, Bravo-Perez, C, López, GR, Arias, RD, Sanz, A, Martinez, MM, Beas, F, Jáuregui, SN, Arias, R, Canela, MP, Saumell, S, Voso, MT, Maciejewski, J, Acha, P, Valcarcel, D, Jerez, A, Montoro, MJ. Bone marrow alterations and clonal hematopoiesis in germline ETV6 mutation carriers without hematologic malignancy. BLOOD. 2025; 146DOI:10.1182/blood-2025-4997. PMID:. IF:23.100(Q1/1D).

Ubieto, AJ, Alós, DG, Dominguez, SR, Magnano, L, Sánchez, S, Vicente, FD, Iacoboni, G, Losada, CM, Manso, RG, Browne, S, Izquierdo, AR, Baumann, T, Bacelar, AG, Santaella, MP, Prieto, PG, De Villambrosia, SG, Bastos-Oreiro, M, Hernandez, AC, De Miguel, LB, Sturla, AL, Abellan, PF, Vidaller, PJP, Amutio, E, Toimil, FS, Pardal, E, Micó, M, Prat, AM, De La Cruz, B, Huerga, S, Landwehr, M, Hernández, I, Andreu, R, De la Cruz, J, Barca, EG. First-line therapy with rituximab vs. rituximab-CHOP in post-transplant monomorphic diffuse large B-cell lymphoma (DLBCL): Long-term real-world evidence from the spanish group of lymphoma (GELTAMO). BLOOD. 2025; 146DOI:10.1182/blood-2025-3677. PMID:. IF:23.100(Q1/1D).

Gurnari, C, Ottone, T, Piciocchi, A, Späth, D, Meid, A, Marsili, G, Fabiani, E, Romano, F, Pascale, MR, Chiusolo, P, Di Ianni, M, Sobas, M, Brunetti, L, Oñate, G, Infante, JB, Nanni, J, Vetro, C, Boada, M, Candoni, A, Sierra, J, Potter, N, Gilkes, A, Johnson, S, Thomas, I, Huntley, B, Russell, N, Dillon, R, Döhner, H, Döhner, K, Voso, MT. Diagnostic evaluation methods and prognostic impact of FLT3-ITD microclones in Acute Myeloid Leukemia (AML): A retrospective multicenter study on behalf of the EHA AML-specialized working group (SWG). BLOOD. 2025; 146DOI:10.1182/blood-2025-217. PMID:. IF:23.100(Q1/1D).

Hernández-Rivas, JA, Prat, AM, Ponce, ES, Medina, A, Lluch-García, R, Oliveira, ACD, Rodriguez-Fernandez, A, Soler, JA, Terol-Castera, MJ, Machado-Machado, P, Pérez-Encinas, M, Romero-Carmona, R, Segundo, LYS, García-Martin, P, Mompo, C, Zubillaga-Marban, E. First worldwide real-life data on fixed-duration ibrutinib plus venetoclax treatment for previously untreated CLL/SLL patients: Updated interim analysis of Spain's LI plus VE observational study. BLOOD. 2025; 146DOI:10.1182/blood-2025-2728. PMID:. IF:23.100(Q1/1D).

Niebla, AM, Gine, E, Bastos-Oreiro, M, Perez, A, Cabirta, A, Vicente, FD, Vilaseca, MC, Ubieto, AJ, De Villambrosia, SG, Prat, AM, Barca, EG, Henriquez, HDL, Herranz, ER, Prieto, PG, Cordoba, R, Carreres, AS, Garcia-Sancho, AM, Moya, AMGN, Grande, C, Martine, PP, Nicolas, C, Gutierrez, A, Rivas, JAH, Sanchez-Gonzalez, B, Villalobos, MT, Garcia-Cerecedo, T, Trillo, RA, Donato, E, Gutierrez, PV, Belmonte, DG, Cozzarelli, SRV, Ordoñez, SS, De La Mano, EP, Avaría, A, Blanco, LV, Roldan-Perez, A, Sancho, JM, De la Cruz, B, Prince-Eladnani, R, Abrisqueta, P. Characterization and outcomes of patients with indolent Mantle Cell Lymphoma (iMCL) in Spain. the GELTAMO-MCL-2022 Study. BLOOD. 2025; 146DOI:10.1182/blood-2025-3592. PMID:. IF:23.100(Q1/1D).

Chatzikonstantinou, T, Agathangelidis, A, Talimtzi, P, Laidou, S, Minga, E, Roussos, A, Angelopoulou, M, De Tomas, MA, Antic, D, Baran-Marszak, F, Bödör, C, Albareda, FB, Catherwood, M, Chatzileontiadou, S, Chessa, C, Coscia, M, Crespo, M, Cuneo, A, Davis, Z, Dimou, M, Doubek, M, Efstathopoulou, M, Espinet, B, Gaidano, G, Gupta, R, Hatzimichael, E, Herishanu, Y, Karamanli, T, Konstantinou, E, Kotsianidis, I, Koumpis, AE, Laszlo, T, Levy, V, Machairas, A, Martini, F, Moia, R, Mouhssine, S, Prat, AM, Murru, R, Mpalaoura, E, Pangalis, G, Papaioannou, M, Pavlova, S, Plevova, K, Pospisilova, S, Puiggros, A, Rani, L, Rigolin, GM, Romano, I, Rossi, D, Serna, A, Simkovic, M, Smolej, L, Stavrogianni, N, Vujovic, KT, Trentin, L, Vassilakopoulos, T, Visentin, A, Vitale, C, Vrachiolias, G, Scarfo, L, Chatzidimitriou, A, Ghia, P, Stamatopoulos, K. Dissecting the heterogeneity of IGHV-mutated CLL: An eric study. BLOOD. 2025; 146DOI:10.1182/blood-2025-2120. PMID:. IF:23.100(Q1/1D).

Bastos-Oreiro, M, Cabirta, A, Perez, A, Carreres, AS, De Villambrosia, SG, Canelo, M, Moya, AMGN, Benito, BD, Gutiérrez, PV, Vicente, FD, Caballero, JC, Jiménez-Ubieto, A, Belmonte, DG, Prat, AM, Barca, EG, Henríquez, HDL, Herranz, ER, Garcia-Sancho, AM, Grande, C, Nicolás, C, Gutierrez, A, Gomez-Llobell, M, Rivas, JAH, Sánchez-González, B, Campos, AF, Trillo, RA, Donato, E, Cozzarell, SRV, Ordoñez, SS, De La Mano, EP, Prieto, PG, Avaria, A, Blanco, LV, Roldán-Pérez, A, Cordoba, R, Sancho, JM, Gine, E, Garces, VN, Abrisqueta, P, Niebla, AM. Central nervous system involvement in Mantle Cell Lymphoma: A retrospective multicenter cohort study from the spanish geltamo group. BLOOD. 2025; 146DOI:10.1182/blood-2025-3585. PMID:. IF:23.100(Q1/1D).